Information about ExpressMedsCanada.to
List of countries where we can ship Hydroxycarbamide:
Latest news releases on Hydroxycarbamide:
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera.
1. Br J Haematol. 2010 Mar;148(6):961-3. doi: 10.1111/j.1365-2141.2009.08019.x. Epub 2009 Nov 23. A unified definition of clinical resistance and intolerance to ...
1. Lancet. 2011 May 14;377(9778):1663-72. doi: 10.1016/S0140-6736(11)60355-3. Hydroxycarbamide in very young children with sickle-cell anaemia: a ...
MHRA PAR; HYDROXYUREA 500 MG CAPSULES, HARD AND HYDROXYCARBAMIDE 500 MG CAPSULES, HARD, PL 10880/0128-9 1 Public Assessment Report Decentralised Procedure
Each capsule contains 500 mg of Hydroxycarbamide. Excipients with known effect: Contains Lactose Monohydrate 42.2 mg. For the full list of excipients, see section 6.1.
Read about the main treatments for sickle cell disease, including medications to prevent pain, blood transfusions and stem cell transplants.
Essential thrombocythaemia (ET) is an acquired myeloproliferative disorder with a prolonged clinical course and a near-normal life expectancy. Therapy is stratified ...
Objective: To evaluate the cost utility of imatinib compared with interferon (IFN)-α or hydroxycarbamide (hydroxyurea) for first-line treatment of chronic myeloid ...
Seminar 2018 www.thelancet.com Vol 376 December 11, 2010 Lancet 2010; 376: 2018–31 Published Online December 4, 2010 DOI:10.1016/S0140-6736(10)61029-X
De MPN Stichting is er voor patiënten met Essentiële Trombocytemie (ET), Polycythaemia Vera (PV) en Myelofibrose (MF).